[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
CAS: 114-07-8
Ref. IN-DA0039A1
5g | 25,00 € | ||
25g | 52,00 € | ||
100g | 119,00 € | ||
500g | 509,00 € |
Produktinformation
- Erycette
- Erymax
- Erythromycin
- Erythromycin A
- Erythromycin C
- Erythromycin Lactate
- Erythromycin Phosphate
- Ilotycin
- Lactate, Erythromycin
- Phosphate, Erythromycin
- Mehr Synonyme anzeigen
- T Stat
- T-Stat
- erythromycin
- Erythromycin A
- E-Mycin
- Abomacetin
- Erythrocin
- Erythromycinum
- Erymax
- Ilotycin
- Erythromycine
- Eritromicina
- Emgel
- Robimycin
- Erythro-Statin
- E-Glades
- E-Base
- erythro
- Benzamycin
- Dumotrycin
- Mephamycin
- Eryacne
- Sansac
- Eryc Sprinkles
- Erythra-Derm
- Akne-Mycin
- Erythromycin base
- R-P Mycin
- Wemid
- E-Solve 2
- Torlamicina
- Abboticin
- Erycette
- Ery-Tab
- Erythroguent
- Eritrocina
- Erycinum
- Erythrogran
- Erythromid
- Pantomicina
- Propiocine
- Stiemycin
- Dotycin
- Ermycin
- Erycen
- Erycin
- Eryderm
- Erygel
- Ilocaps
- Aknin
- Pfizer-E
- Theramycin Z
- Kesso-Mycin
- Taimoxin-F
- Ak-Mycin
- Erythromast 36
- Erythromycin Lactate
- T-Stat
- Endoeritrin
- Eritomicina
- Erythroderm
- Erytrociclin
- Paediathrocin
- Pharyngocin
- Proterytrin
- Acneryne
- Acnesol
- Aknemycin
- Derimer
- Deripil
- Erisone
- Eryacnen
- Erydermer
- Eryhexal
- Erysafe
- Iloticina
- Latotryd
- Lederpax
- Mercina
- Oftamolets
- Pantoderm
- Pantodrin
- Primacine
- Romycin
- Stiemicyn
- Tiloryth
- Tiprocin
- Emuvin
- Emycin
- Erecin
- Erymed
- Erytab
- Erytop
- Inderm
- Retcin
- AustriaS
- Eros
- Ery-maxin
- Erythro-Teva
- Sans-acne
- Erimycin-T
- Ery-Diolan
- Inderm Gel
- Del-Mycin
- Wyamycin S
- Aknederm Ery Gel
- Udima Ery Gel
- Emu-Ve
- Erythrocin stearate
- Skid Gel E
- Akne Cordes Losung
- Ilosone (estolate)
- E-Mycin (base)
- Ery-Tab (base)
- E-Base (base)
- Emu-V
- Ery-B
- C-Solve-2
- IndermRetcin
- erythromycin-A
- A/T/S
- Oftalmolosa Cusi Eritromicina
- Ilotycin gluceptate
- (-)-Erythromycin, 98%
- (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione
- Ilotycin T.S.
- (-)-Erythromycin, Eur.Ph.
- N-Methylerythromycin A
- Ery-Sol
- (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan-13-olide
- erthromycin
- Erythromycines
- E-mycin, Erythrocin
- Erythromycin(E-Mycin)
- Erythromycin A, B + C
- Erythromycin (mixture of A,B,C)
- Erythromycin, labeled with carbon-13
- Erythromycin, tested according to Ph.Eur.
- Erythromycin, N-demethyl-N-(methyl-11C)-
- Erythromycin, plant cell culture tested, ~98%
- Erythromycin, Biotechnology Performance Certified
- 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- Erythromycin, Antibiotic for Culture Media Use Only
- Erythromycin, BioReagent, suitable for cell culture
- Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
- (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- (3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- Drmysin
- E-mycin
- E.E.S
- EMU
- Ergel
- Eritocina
- Eritrex
- Eritromed
- Erthrogran
- Ery Derm
- Ery-Ped
- EryDerm
- Eryc
- Erythro
- Erythromast
- Ilocap
- Ilosone
- L-alpha-Egg-phosphatidylcholine
- Nsc 55929
- Oxacyclotetradecane, erythromycin deriv.
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- P.C.E.
- PCE
- Pediamycin
- Statcin
- Staticin
- Torlamicna
- Vetwic
- Wintrocin
- Wyamycin-s
- [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
Chemische Eigenschaften
Technische Anfrage zu: IN-DA0039A1 [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.